Table 1.
Clinical characteristics of patients with MAPs.
| Characteristic | Right side (n = 13) | Left side (n = 4) | P-value | X 2 |
|---|---|---|---|---|
| Female, n (%) | 54.8% (7/13) | 50% (2/4) | 0.89 | 0.018 |
| Age, years | 47 (28-66) | 56 (31-79) | 0.42 | |
| Clinical features | ||||
| Palpitation | 100% (13/13) | 100% (4/4) | ||
| ECG documented tachycardia | 84.6% (11/13) | 100% (4/4) | 0.40 | 0.697 |
| Syncope | 0% (0/13) | 0% (0/4) | ||
| Drugs | ||||
| Calcium channel blocker | 23.1% (3/13) | 25% (1/4) | 0.87 | 0.023 |
| Beta blocker | 38.5% (5/13) | 25% (1/4) | 0.62 | 0.243 |
| No medication | 38.5% (5/13) | 50% (2/4) | 0.68 | 0.168 |
| Electrocardiogram | ||||
| Minimal pre-excitation during sinus rhythm | 38.5% (5/13) | 25% (1/4) | 0.62 | 0.243 |
| No pre-excitation | 61.5% (8/13) | 75% (3/4) | 0.62 | 0.243 |